1. Home
  2. ALG vs PTGX Comparison

ALG vs PTGX Comparison

Compare ALG & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alamo Group Inc.

ALG

Alamo Group Inc.

HOLD

Current Price

$163.60

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$102.29

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALG
PTGX
Founded
1955
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
5.2B
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
ALG
PTGX
Price
$163.60
$102.29
Analyst Decision
Buy
Strong Buy
Analyst Count
3
12
Target Price
$225.00
$100.17
AVG Volume (30 Days)
139.8K
636.5K
Earning Date
03-02-2026
05-05-2026
Dividend Yield
0.81%
N/A
EPS Growth
N/A
N/A
EPS
8.59
N/A
Revenue
$1,603,715,000.00
N/A
Revenue This Year
$8.06
$711.26
Revenue Next Year
$2.19
N/A
P/E Ratio
$19.52
N/A
Revenue Growth
N/A
N/A
52 Week Low
$156.30
$39.60
52 Week High
$233.29
$100.00

Technical Indicators

Market Signals
Indicator
ALG
PTGX
Relative Strength Index (RSI) 30.86 70.36
Support Level $160.48 $76.63
Resistance Level $185.55 N/A
Average True Range (ATR) 7.84 4.83
MACD -2.25 0.60
Stochastic Oscillator 8.12 81.87

Price Performance

Historical Comparison
ALG
PTGX

About ALG Alamo Group Inc.

Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial, and agricultural use. Its products include agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck-mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, snow removal equipment, etc. The company's reportable segments are Vegetation Management, which generates the maximum revenue, and Industrial Equipment. Geographically, the company generates maximum revenue from the United States, followed by Canada, France, the UK, Brazil, the Netherlands, and other regions.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Share on Social Networks: